Analysts' Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), LAVA Therapeutics (LVTX) and Aura Biosciences Inc (AURA)
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Generation Bio (GBIO)
Generation Bio Analyst Ratings
Wedbush Remains a Buy on Generation Bio (GBIO)
Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Generation Bio (GBIO)
Analysts Are Bullish on These Healthcare Stocks: Generation Bio (GBIO), Poseida Therapeutics (PSTX)
Generation Bio Analyst Ratings
Analysts' Top Healthcare Picks: Generation Bio (GBIO), Curaleaf Holdings (CURLF)
Generation Bio Analyst Ratings
JMP Securities Keeps Their Hold Rating on Generation Bio (GBIO)
Analysts Conflicted on These Healthcare Names: Generation Bio (GBIO), RegenXBio (RGNX) and Halozyme (HALO)
Analysts' Top Healthcare Picks: Ardelyx (ARDX), Generation Bio (GBIO)
JMP Securities Keeps Their Hold Rating on Generation Bio (GBIO)
Wedbush Adjusts Generation Bio Price Target to $5 From $9, Maintains Outperform Rating
Analyst Upholds Buy Rating for Generation Bio Based on 3Q23 Earnings and Strong Financial Health
Promising Developments in IqDNA Technology and Robust Financial Position Elevate Generation Bio's Stock Rating: An Analysis by David Nierengarten
Generation Bio Analyst Ratings
Wedbush Lowers Generation Bio's Price Target to $9 From $11, Maintains Outperform Rating
Generation Bio (GBIO) Gets a Hold From TD Cowen
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Nuvation Bio (NUVB) and Generation Bio (GBIO)